Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 42 | 1 | 38 | −3 |
| Shares | 3.82M | 500 | 3.61M | −210.1K (−5.5%) |
| Value | $5.23M | $1.00K | $4.58M | −$655.4K (−12.5%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CWA Asset Management Group, LLC | 83,333 | $105.0K | 0.01% |
| Forefront Wealth Partners, LLC | 65,000 | $81.9K | 0.06% |
| Gsa Capital Partners LLP | 44,633 | $56.0K | 0.01% |
| JustInvest LLC | 20,439 | $25.8K | 0.00% |
| Susquehanna International Group, LLP | 16,554 | $20.9K | 0.00% |
| Citigroup Inc | 313 | $394 | 0.00% |
Sold out (9)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Investments, LP | 291,381 | $399.2K |
| Citadel Advisors LLC | 118,966 | $163.0K |
| Two Sigma Advisers, LP | 110,163 | $150.9K |
| Virtu Financial LLC | 45,404 | $62.0K |
| Ground Swell Capital, LLC | 17,153 | $23.5K |
| Stifel Financial Corp | 14,684 | $20.1K |
| Squarepoint Ops LLC | 10,863 | $14.9K |
| Commonwealth Equity Services, LLC | 10,409 | $14.0K |
| R Squared Ltd | 2,170 | $2.97K |
Not filed for Q1 2025 yet (1)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| AlphaMark Advisors, LLC | 500 | $1.00K |